Public Health, Jimma University College of Public Health and Medical Sciences, Jimma, Oromia, Ethiopia
Jimma University Clinical Trial Unit, Jimma, Oromia, UK.
BMJ Open. 2024 Feb 10;14(2):e077151. doi: 10.1136/bmjopen-2023-077151.
This systematic review and meta-analysis aimed to assess the magnitude and determinants of diabetic ketoacidosis (DKA) among patients with diabetes mellitus (DM) in Ethiopia.
Systematic review and meta-analysis.
Age 15 and above all patients with diabetes with the diagnosis of DKA in Ethiopia DATA SOURCE: PubMed/MEDLINE, Cochrane Library, Science Direct, HINARI, Google Scholar and grey literatures were accessed to find relevant articles. Studies that have been conducted and reported in English language, articles with an available full-text, and observational studies were included. The task of searching sources was carried out from all stated electronic databases performed during 15 April-29 April 2023.
Eligible studies were critically appraised by three independent reviewers for methodological quality in the review using standardised critical appraisal instruments from Joanna Briggs Institute (JBI) for observational studies. After the finally extracted studies were exported, systematic review and meta-analysis were conducted using Unified Management, Assessment and Review of Information (JBI SUMARI) (JBI, Adelaide, Australia) and STATA V.17 software. Sensitivity tests were done, and funnel plot inspections with Egger's test were used to check for publication bias.
From a total of 19 studies with 6498 study participants, the pooled prevalence of DKA among patients with DM in Ethiopia was 30.92% (95% CI 29.96 to 31.89) with a significant statistical heterogeneity (I=99.2, p=<0.001). Sensitivity analysis suggested that three studies showed deviations from the estimated pooled prevalence. A funnel plot inspection and Egger's test indicated the absence of a publication bias.
This systematic review and meta-analysis revealed that the prevalence of DKA among patients with DM in Ethiopia was 30.92%. Besides, different behavioural and clinical determinants of DKA among patients with DM were identified. However, further studies should be conducted, particularly on the possible determinants of DKA, and different stakeholders should be engaged to minimise its burden.
本系统评价和荟萃分析旨在评估埃塞俄比亚糖尿病患者中糖尿病酮症酸中毒(DKA)的发生程度和决定因素。
系统评价和荟萃分析。
年龄在 15 岁及以上的所有糖尿病患者,在埃塞俄比亚被诊断为 DKA。
通过 PubMed/MEDLINE、Cochrane 图书馆、Science Direct、HINARI、Google Scholar 和灰色文献检索相关文章。纳入了已开展并以英文报告、可提供全文的文章和观察性研究。检索工作于 2023 年 4 月 15 日至 4 月 29 日在所有指定的电子数据库中进行。
使用 Joanna Briggs 研究所(JBI)针对观察性研究的标准批判性评估工具,由三名独立评审员对合格研究进行方法学质量的批判性评估。在最终提取的研究被导出后,使用统一管理、评估和信息审查(JBI SUMARI)(JBI,澳大利亚阿德莱德)和 STATA V.17 软件进行系统评价和荟萃分析。进行了敏感性测试,并使用漏斗图检查和 Egger 检验检查发表偏倚。
共有 19 项研究,涉及 6498 名研究参与者,埃塞俄比亚糖尿病患者中 DKA 的总患病率为 30.92%(95%CI 29.96 至 31.89),具有显著的统计学异质性(I=99.2,p<0.001)。敏感性分析表明,有三项研究偏离了估计的汇总患病率。漏斗图检查和 Egger 检验表明不存在发表偏倚。
本系统评价和荟萃分析显示,埃塞俄比亚糖尿病患者中 DKA 的患病率为 30.92%。此外,还确定了糖尿病患者 DKA 的不同行为和临床决定因素。然而,应该进行进一步的研究,特别是关于 DKA 的可能决定因素,并且应该让不同的利益相关者参与进来,以减轻其负担。